All terms in HP

Label Id Description
Reduced circulating C-reactive protein concecntration HP_0032437 [An abnormal decrease of the C-reactive protein level in serum.]
Abnormal circulating C-reactive protein concentration HP_0032436 [Any deviation from the normal concentration of C-reactive protein in the blood circulation.]
Neonatal omphalitis HP_0032435 [An infection of the umbilicus and/or surrounding tissues occurring in the neonatal period.]
heteroorganic entity CHEBI_33285 [A heteroorganic entity is an organic molecular entity in which carbon atoms or organic groups are bonded directly to one or more heteroatoms.]
amelogenesis GO_0097186 [The process whose specific outcome is the formation of tooth enamel, occurring in two stages: secretory stage and maturation stage.]
odontogenesis of dentin-containing tooth GO_0042475 [The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel.]
Focal friction-related palmoplantar hyperkeratosis HP_0007497 [Hyperkeratosis affecting the palm of the hand and the sole of the foot in areas exposed to friction.]
Discrete 2 to 5-mm hyper- and hypopigmented macules HP_0007494
negative regulation of production of molecular mediator of immune response GO_0002701 [Any process that stops, prevents, or reduces the frequency, rate, or extent of the production of molecular mediator of immune response.]
negative regulation of antimicrobial humoral response GO_0008348 [Any process that stops, prevents, or reduces the frequency, rate, or extent of an antimicrobial humoral response.]
regulation of production of molecular mediator of immune response GO_0002700 [Any process that modulates the frequency, rate, or extent of the production of molecular mediator of immune response.]
regulation of antimicrobial humoral response GO_0002759 [Any process that modulates the frequency, rate, or extent of an antimicrobial humoral response.]
Delayed umbilical cord separation HP_0032434 [Separation of the umbilical cord occurs at an abnormally late timepoint.]
Decreased HDL3c concentration HP_0032433 [A reduction below the normal concentration of the HDL3c subfraction in the blood circulation. An HDL3c particle is defined as an HDL particle with a size of 7.20-7.79 nm.]
Increased HDL3c concentration HP_0032432 [An elevation above the normal concentration of the HDL3c subfraction in the blood circulation. An HDL3c particle is defined as an HDL particle with a size of 7.20-7.79 nm.]
Decreased HDL3b concentration HP_0032431 [A reduction below the normal concentration of the HDL3b subfraction in the blood circulation. An HDL3b particle is defined as an HDL particle with a size of 7.8-8.19 nm.]
Increased HDL3b concentration HP_0032430 [An elevation above the normal concentration of the HDL3b subfraction in the blood circulation. An HDL3b particle is defined as an HDL particle with a size of 7.8-8.19 nm.]
apoptotic signaling pathway GO_0097190 [The series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered.]
Anti-asialoglycoprotein receptor antibody positivity HP_0032469 [Presence of autoantibodies against the asialoglycoprotein receptor (ASGPR) in the blood circulation.]
execution phase of apoptosis GO_0097194 [A stage of the apoptotic process that starts with the controlled breakdown of the cell through the action of effector caspases or other effector molecules (e.g. cathepsins, calpains etc.). Key steps of the execution phase are rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.]